Biofrontera Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Resumen detallado
On November 16, 2026, Biofrontera received notice that its common stock was below Nasdaq's $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule…
On November 16, 2026, Biofrontera received notice that its common stock was below Nasdaq's $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on trading, and the company has until May 17, 2027, to regain compliance by meeting the minimum bid price for at least 10 consecutive business days. If it does not, it may qualify for an additional compliance period; delisting is possible if it fails to meet Nasdaq's requirements.
Inicio del artículo, extracto de TradingView. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.tradingview.com)




